In a report released yesterday, Chris Lui from Jefferies maintained a Buy rating on Shandong Weigao Group Medical Polymer Co (SHWGF – Research Report), with a price target of HK$17.00. The company’s shares closed last Friday at $0.96.
According to TipRanks, Lui is an analyst with an average return of -14.1% and a 26.83% success rate. Lui covers the Healthcare sector, focusing on stocks such as Innovent Biologics, Alibaba Health Information Technology, and CSPC Pharmaceutical Group.
Currently, the analyst consensus on Shandong Weigao Group Medical Polymer Co is a Moderate Buy with an average price target of $2.18.
See the top stocks recommended by analysts >>
SHWGF market cap is currently $4.34B and has a P/E ratio of 12.37.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Shandong Weigao Group Medical Polymer Co (SHWGF) Company Description:
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
